"10.1371_journal.pone.0049612","plos one","2012-11-21T00:00:00Z","Sandrine Braud; Marco A Ciufolini; Itzik Harosh","ObeTherapy Biotechnology, Evry, France; Department of Chemistry, The University of British Columbia, Vancouver, British Columbia, Canada","Conceived and designed the experiments: SB IH. Performed the experiments: SB. Analyzed the data: SB IH. Wrote the paper: SB MAC IH. Consultant for the chemistry aspects of this work: MAC.","The authors have the following interest. Sandrine Braud and Itzik Harosh are employees of and shareholders in ObeTherapy Biotechnology. Marco A. Ciufolini is a scientific advisor to ObeTherapy Biotechnology. ObeTherapy is the proprietary holder of the compounds described herein. There are no further products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","11","Sandrine Braud","SB",3,TRUE,2,1,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
